Kaken Pharmaceutical Co., Ltd. (TYO:4521)

Japan · Delayed Price · Currency is JPY

4,265.00

+20.00 (0.47%)

At close: Mar 5, 2026

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Real Estate	2.48B	2.43B	2.42B	2.41B	2.37B
Real Estate Growth	2.10%	0.33%	0.50%	1.90%	-0.55%
Pharmaceutical Industry	91.55B	69.61B	70.56B	73.62B	72.61B
Pharmaceutical Industry Growth	31.52%	-1.34%	-4.16%	1.39%	-16.39%
Total	94.03B	72.04B	72.98B	76.03B	74.98B
Total Growth	30.52%	-1.29%	-4.01%	1.41%	-15.97%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Japan	94.04B	72.04B	72.98B	76.03B	74.98B
Japan Growth	30.52%	-1.29%	-4.01%	1.41%	-15.97%
Total	94.04B	72.04B	72.98B	76.03B	74.98B
Total Growth	30.52%	-1.29%	-4.01%	1.41%	-15.97%

Source: S&P Global Market Intelligence.